Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rutger K Balvers

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
AACE Clinical Case Reports|May 23, 2022
Complicated Clinical Course in Incipient Gigantism Due to Treatment-resistant Aryl Hydrocarbon Receptor-Interacting Protein-mutated Pediatric SomatotropinomaSelveta Sanne van Santen, Adrian F Daly, Michael Buchfelder, et al.
Ebiomedicine|March 22, 2024
Potential of PSMA-targeting radioligand therapy for malignant primary and secondary brain tumours using super-selective intra-arterial administration: a single centre, open label, non-randomised prospective imaging studyIlanah J Pruis, Pieter Jan van Doormaal, Rutger K Balvers, et al.
Journal of Neuro-Oncology|February 6, 2025
Between-hospital variation in biopsy indication for patients with newly diagnosed glioblastoma in the Dutch Quality Registry for NeurosurgeryIlaria Viozzi, Gerjon Hannink, Hilko Ardon, et al.
Cancers|February 26, 2025
Ultrasonic Aspiration-Acquired Glioblastoma Tissue Preserves Lymphocyte Phenotype and Viability, Supporting Its Use for Immunological StudiesEftychia Stavrakaki, Zineb Belcaid, Rutger K Balvers, et al.
Annals of Clinical and Translational Neurology|February 21, 2025
Clinical impact and safety of brain biopsy in unexplained central nervous system disorders: a real-world cohort studyRobin W van Steenhoven, Saan Salih, Juna M de Vries, et al.
Journal of Neuro-Oncology|January 29, 2021
Between-hospital variation in rates of complications and decline of patient performance after glioblastoma surgery in the dutch Quality Registry Neuro SurgeryIvar Kommers, Linda Ackermans, Hilko Ardon, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 15, 2023
Mimics of Autoimmune Encephalitis: Validation of the 2016 Clinical Autoimmune Encephalitis CriteriaRobin W Van Steenhoven, Juna M de Vries, Arlette L Bruijstens, et al.
Journal of Neurosurgery|March 11, 2022
Between-hospital variation in time to glioblastoma surgery: a report from the Quality Registry Neuro Surgery in the NetherlandsMerijn E De Swart, Domenique M J Müller, Hilko Ardon, et al.
Journal of Neuro-Oncology|May 23, 2025
Survival prediction in glioblastoma: 10-year follow-up from the Dutch Neurosurgery Quality RegistryJeroen T J M van Dijck, Hilko Ardon, Rutger K Balvers, et al.
Molecular Cancer|August 10, 2023
Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trialEelke M Bos, Elena Binda, Iris S C Verploegh, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
AACE Clinical Case Reports|May 23, 2022
Complicated Clinical Course in Incipient Gigantism Due to Treatment-resistant Aryl Hydrocarbon Receptor-Interacting Protein-mutated Pediatric SomatotropinomaSelveta Sanne van Santen, Adrian F Daly, Michael Buchfelder, et al.
Ebiomedicine|March 22, 2024
Potential of PSMA-targeting radioligand therapy for malignant primary and secondary brain tumours using super-selective intra-arterial administration: a single centre, open label, non-randomised prospective imaging studyIlanah J Pruis, Pieter Jan van Doormaal, Rutger K Balvers, et al.
Journal of Neuro-Oncology|February 6, 2025
Between-hospital variation in biopsy indication for patients with newly diagnosed glioblastoma in the Dutch Quality Registry for NeurosurgeryIlaria Viozzi, Gerjon Hannink, Hilko Ardon, et al.
Cancers|February 26, 2025
Ultrasonic Aspiration-Acquired Glioblastoma Tissue Preserves Lymphocyte Phenotype and Viability, Supporting Its Use for Immunological StudiesEftychia Stavrakaki, Zineb Belcaid, Rutger K Balvers, et al.
Annals of Clinical and Translational Neurology|February 21, 2025
Clinical impact and safety of brain biopsy in unexplained central nervous system disorders: a real-world cohort studyRobin W van Steenhoven, Saan Salih, Juna M de Vries, et al.
Journal of Neuro-Oncology|January 29, 2021
Between-hospital variation in rates of complications and decline of patient performance after glioblastoma surgery in the dutch Quality Registry Neuro SurgeryIvar Kommers, Linda Ackermans, Hilko Ardon, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 15, 2023
Mimics of Autoimmune Encephalitis: Validation of the 2016 Clinical Autoimmune Encephalitis CriteriaRobin W Van Steenhoven, Juna M de Vries, Arlette L Bruijstens, et al.
Journal of Neurosurgery|March 11, 2022
Between-hospital variation in time to glioblastoma surgery: a report from the Quality Registry Neuro Surgery in the NetherlandsMerijn E De Swart, Domenique M J Müller, Hilko Ardon, et al.
Journal of Neuro-Oncology|May 23, 2025
Survival prediction in glioblastoma: 10-year follow-up from the Dutch Neurosurgery Quality RegistryJeroen T J M van Dijck, Hilko Ardon, Rutger K Balvers, et al.
Molecular Cancer|August 10, 2023
Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trialEelke M Bos, Elena Binda, Iris S C Verploegh, et al.
Pageof 3